Head-to-head · Cost-Efficiency Index
LunaRx vs Allara Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
LunaRx
Shoppers who value simple flat-rate pricing and a no-cost-if-declined guarantee over named clinical credentials.
Visit LunaRxAllara Health
Cost-first shoppers who want insured patients who want women's hormonal-health specialists to manage a GLP-1 prescription, not shoppers pricing the drug itself.
Visit Allara HealthThe verdict
LunaRx takes it, leading the Cost-Efficiency Index 63 to 62. LunaRx is a telehealth weight-loss platform advertising flat-rate pricing ($149/mo and $199/mo tiers) with a '$0 if not approved' consult guarantee. Allara Health still earns a C — Cost-first shoppers who want insured patients who want women's hormonal-health specialists to manage a GLP-1 prescription, not shoppers pricing the drug itself.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs LunaRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | LunaRx | Allara Health |
|---|---|---|
| Cost-Efficiency Index | 63/100 | 62/100 |
| Semaglutide / mo | $149/mo (compounded) | $149/mo (plus a separate fee, brand-name) |
| Tirzepatide / mo | $199/mo (compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $1,788 | $1,788 |
| Tirzepatide / yr (modeled) | $2,388 | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #197 | #204 |
LunaRx
63/100Where the value is
- Advertises simple, flat-rate pricing with no hidden fees
- '$0 if not approved' removes financial risk from a declined consult
- Founder is publicly named (Anamaria Galvan, RN) rather than fully anonymous leadership
The tradeoffs
- No named physician medical director -- only an RN founder is identified
- No named compounding pharmacy partner
Allara Health
62/100Where the value is
- In-network with major insurers (Aetna, Blue Cross Blue Shield/Anthem/Carefirst, Cigna, United Healthcare/Oxford/UMR, GEHA), which can make branded GLP-1s cheaper than any cash-pay compounded option for covered patients
- Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound) rather than unapproved compounded preparations
- Board-certified OB-GYNs, endocrinologists, and Registered Dietitians on a women's-health-specialized platform
The tradeoffs
- No GLP-1 medication price is published anywhere on the site — the $149/mo figure is a visit/membership fee only, and actual drug cost depends entirely on insurance or is undisclosed for self-pay
- Not a general low-cost GLP-1 shopping option — the platform is built around women's hormonal/PCOS specialty care, with GLP-1 as one treatment among many
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.